<?xml version="1.0" encoding="UTF-8"?>
<ref id="B79-microorganisms-08-00085">
 <label>79.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dubey</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Graves</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>DeSena</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Frohman</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Greenberg</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: Case report and review of literature</article-title>
  <source>Ther. Adv. Neurol. Disord.</source>
  <year>2016</year>
  <volume>9</volume>
  <fpage>211</fpage>
  <lpage>215</lpage>
  <pub-id pub-id-type="doi">10.1177/1756285615621029</pub-id>
  <pub-id pub-id-type="pmid">27134676</pub-id>
 </element-citation>
</ref>
